Ernst Heinen
2017
In 2017, Ernst Heinen earned a total compensation of $801.9K as Chief Development Officer at Aratana Therapeutics, a 17% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $83,200 |
|---|---|
| Option Awards | $199,142 |
| Salary | $315,000 |
| Stock Awards | $204,510 |
| Total | $801,852 |
Heinen received $315K in salary, accounting for 39% of the total pay in 2017.
Heinen also received $83.2K in non-equity incentive plan, $199.1K in option awards and $204.5K in stock awards.
Rankings
In 2017, Ernst Heinen's compensation ranked 10,011th out of 14,666 executives tracked by ExecPay. In other words, Heinen earned more than 31.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,011 out of 14,666 | 32nd |
Division Manufacturing | 3,869 out of 5,768 | 33rd |
Major group Chemicals And Allied Products | 1,351 out of 2,074 | 35th |
Industry group Drugs | 1,095 out of 1,730 | 37th |
Industry Pharmaceutical Preparations | 856 out of 1,329 | 36th |
Source: SEC filing on June 8, 2018.
Heinen's colleagues
We found three more compensation records of executives who worked with Ernst Heinen at Aratana Therapeutics in 2017.